MIC
PFE icon

Meridian Investment Counsel’s Pfizer PFE Stock Holding History

Meridian Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Sell
50,187
-4,738
-9% -$124K 0.26% 105
2026
Q1 		$1.54M Sell
54,925
-8,578
-14% -$228K 0.37% 88
2025
Q4 		$1.58M Sell
63,503
-4,572
-7% -$115K 0.38% 82
2025
Q3 		$1.73M Sell
68,075
-1,350
-2% -$33.3K 0.43% 74
2025
Q2 		$1.68M Sell
69,425
-449
-0.6% -$10.5K 0.46% 70
2025
Q1 		$1.77M Buy
69,874
+4,717
+7% +$123K 0.52% 63
2024
Q4 		$1.73M Buy
65,157
+2,137
+3% +$58K 0.52% 58
2024
Q3 		$1.82M Sell
63,020
-1,891
-3% -$55.2K 0.55% 57
2024
Q2 		$1.82M Buy
64,911
+400
+0.6% +$11K 0.57% 51
2024
Q1 		$1.79M Sell
64,511
-867
-1% -$24.1K 0.6% 53
2023
Q4 		$1.88M Sell
65,378
-65
-0.1% -$1.97K 0.65% 50
2023
Q3 		$2.17M Sell
65,443
-1,600
-2% -$56.6K 0.81% 35
2023
Q2 		$2.46M Sell
67,043
-1,000
-1% -$38.9K 0.88% 32
2023
Q1 		$2.78M Sell
68,043
-90
-0.1% -$3.89K 1.05% 23
2022
Q4 		$3.49M Sell
68,133
-1,337
-2% -$64.1K 1.39% 15
2022
Q3 		$3.04M Sell
69,470
-3,355
-5% -$163K 1.35% 16
2022
Q2 		$3.82M Sell
72,825
-1,300
-2% -$66.2K 1.57% 13
2022
Q1 		$3.84M Hold
74,125
– – 1.33% 17
2021
Q4 		$4.38M Sell
74,125
-1,078
-1% -$53.4K 1.45% 14
2021
Q3 		$3.23M Sell
75,203
-150
-0.2% -$6.64K 1.17% 22
2021
Q2 		$2.95M Buy
75,353
+1,500
+2% +$58.3K 1.04% 24
2021
Q1 		$2.68M Buy
73,853
+21
+0% +$746 1.03% 26
2020
Q4 		$2.72M Sell
73,832
-2,542
-3% -$93.2K 1.15% 23
2020
Q3 		$2.66M Buy
76,374
+1,341
+2% +$47K 1.29% 22
2020
Q2 		$2.33M Buy
75,033
+339
+0.5% +$11.5K 1.19% 21
2020
Q1 		$2.31M Buy
74,694
+642
+0.9% +$21.9K 1.5% 17
2019
Q4 		$2.75M Buy
74,052
+10,493
+17% +$374K 1.36% 17
2019
Q3 		$2.17M Buy
63,559
+22
+0% +$800 1.18% 24
2019
Q2 		$2.61M Sell
63,537
-625
-1% -$24.8K 1.44% 18
2019
Q1 		$2.58M Buy
64,162
+18
+0% +$721 1.51% 15
2018
Q4 		$2.66M Sell
64,144
-696
-1% -$28.9K 1.74% 10
2018
Q3 		$2.71M Buy
64,840
+17
+0% +$654 1.48% 14
2018
Q2 		$2.23M Sell
64,823
-138
-0.2% -$4.72K 1.26% 21
2018
Q1 		$2.19M Sell
64,961
-190
-0.3% -$6.53K 1.24% 24
2017
Q4 		$2.24M Sell
65,151
-193
-0.3% -$6.58K 1.21% 25
2017
Q3 		$2.21M Sell
65,344
-401
-0.6% -$12.9K 1.28% 21
2017
Q2 		$2.1M Buy
65,745
+19
+0% +$599 1.25% 19
2017
Q1 		$2.13M Buy
65,726
+224
+0.3% +$7.06K 1.31% 19
2016
Q4 		$2.02M Sell
65,502
-1,338
-2% -$40.8K 1.35% 19
2016
Q3 		$2.15M Buy
66,840
+246
+0.4% +$8.23K 1.44% 16
2016
Q2 		$2.23M Sell
66,594
-1,353
-2% -$43.2K 1.51% 14
2016
Q1 		$1.91M Buy
67,947
+124
+0.2% +$3.54K 1.34% 21
2015
Q4 		$2.08M Buy
67,823
+16
+0% +$503 1.53% 15
2015
Q3 		$2.02M Sell
67,807
-4,526
-6% -$145K 1.66% 14
2015
Q2 		$2.3M Buy
72,333
+16
+0% +$521 1.65% 12
2015
Q1 		$2.39M Buy
72,317
+1,069
+2% +$34K 1.66% 12
2014
Q4 		$2.11M Sell
71,248
-618
-0.9% -$17.7K 1.52% 14
2014
Q3 		$2.02M Buy
71,866
+13,772
+24% +$387K 1.51% 15
2014
Q2 		$1.64M Buy
58,094
+902
+2% +$25.7K 1.26% 23
2014
Q1 		$1.74M Sell
57,192
-1,040
-2% -$31K 1.48% 15
2013
Q4 		$1.69M Buy
+58,232
New +$1.69M 1.43% 18

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Meridian Investment Counsel's PFE Position: Q2 2026 in Review

Meridian Investment Counsel reduced its Pfizer (PFE) stake by 8.6% in Q2 2026, selling an estimated $124K and leaving 50,187 shares worth $1.21M. The position accounts for 0.26% of the portfolio, ranked #105.

Meridian Investment Counsel first reported a position in PFE in Q4 2013 and has held it in 51 quarters since. The position peaked at $4.38M in Q4 2021. 1,178 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Meridian Investment Counsel held 50,187 shares of Pfizer worth $1.21M as of Q2 2026.
  • Meridian Investment Counsel sold 4,738 Pfizer shares in Q2 2026, an estimated $124K.
  • Pfizer made up 0.26% of Meridian Investment Counsel's portfolio in Q2 2026, its #105 holding.
  • Meridian Investment Counsel first reported a position in Pfizer in Q4 2013 and has held it in 51 quarters since.
  • Meridian Investment Counsel's Pfizer position peaked at $4.38M in Q4 2021.
  • 1,178 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Meridian Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.